Table 3.
The prognostic value of PS in different risk scores.
Risk score | Patients (n) | Univariate analyses | Multivariate analyses | Variables included in multivariate analysis* | |||
---|---|---|---|---|---|---|---|
PS 0 | PS 1 | HR (95%CI) | P value | HR (95%CI) | P value | ||
0 | 556 | 110 | 0.73 (0.44-1.22) | 0.235 | 0.75 (0.45-1.25) | 0.274 | Age, Tumor number |
5 | 228 | 45 | 0.45 (0.26-0.87) | 0.016 | 0.50 (0.27-0.90) | 0.022 | PLT |
8 | 234 | 105 | 0.49 (0.33-0.74) | 0.001 | 0.50 (0.33-0.75) | 0.001 | Albumin |
10 | 10 | 2 | 28.0 (0.01-39.0) | 0.490 | 28.2 (0.00-40.1) | 0.988 | PLT, BUN, Age |
13 | 156 | 76 | 0.69 (0.46-1.05) | 0.084 | 0.70 (0.46-1.06) | 0.091 | PLT |
18 | 9 | 4 | 0.69 (0.15-3.11) | 0.633 | 0.37 (0.06-2.17) | 0.275 | AST |
* Variables with statistically significant differences in univariate analysis and included in multivariate analysis for adjustment.
HR, hazard ratio; CI, confidence interval; PS, performance status; AST, aspartate aminotransferase; PLT, platelet count; BUN, blood urea nitrogen.